Neuphoria Therapeutics, Inc. is a clinical-stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders.
Neuphoria Therapeutics stock last closed at $5.20, up 1.19% from the previous day, and has decreased 54.86% in one year. It has overperformed other stocks in the Biotechnology industry by 0.23 percentage points. Neuphoria Therapeutics stock is currently +144.82% from its 52-week low of $2.12, and -65.88% from its 52-week high of $15.24.
As of Apr 21, 2025, there are 1.76M NEUP shares outstanding. The market value of NEUP is $9.14M. In the last 24 hours, 4493 NEUP shares were traded.
How to Buy Neuphoria Therapeutics Stock
Wondering how to invest in Neuphoria Therapeutics stock? Here's how.
Choose where to buy Neuphoria Therapeutics stock: You need to decide on an online brokerage, but don't worry - we've tried dozens of online brokerages and apps to help you figure out where to buy Neuphoria Therapeutics stock.
Create your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected.
Put funds into your investment account: Pick your method of payment and add your information.
Research Neuphoria Therapeutics stock: The Neuphoria Therapeutics ticker symbol is NEUP. Is Neuphoria Therapeutics stock a good investment? Should you buy shares of NEUP? How do NEUP's underlying business fundamentals look? Do top analysts think Neuphoria Therapeutics is a good buy? Why has NEUP's stock price moved recently? (Hint: Our stock market research tools can help you figure out if NEUP is a good stock to buy).
Execute your NEUP trade: Decide if you will purchase NEUP shares at the current market price or use a limit order to purchase NEUP shares at a given price.
Get key alerts regarding your investment in NEUP: Create a watchlist to important updates regarding your investment in Neuphoria Therapeutics shares.
Step 1: Choose where to buy Neuphoria Therapeutics stock
You will need a brokerage account to access the NASDAQ market and buy NEUP stock.
A brokerage account is an investment account that enables you to buy and sell a variety of financial instruments, such as stocks, bonds, mutual funds, and ETFs.
Our recommended brokerage: eToro
In our opinion, eToro is the best online stock brokerage. Here's why:
Invest in stocks with zero commissions: Invest without paying trading commissions.
Buy fractional shares: Even if you don't have the money to buy a full share, you can still purchase the stock.
Access to world markets: From Technology to Energy, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's leading exchanges.
Social investing: eToro boasts a community with more than 20 million users globally. Talk to, learn from, and copy the crypto trades of top investors.
Security: eToro is a regulated and licensed fintech leader.
Buy other assets: Such as ETFs and cryptos.
Get $10 towards your purchase of stock by signing up for an account with eToro now. This offer is only for US users.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Create your brokerage account
Now that you've chosen the right brokerage, you need to fill out some personal information so you are able to invest in NEUP today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Research Neuphoria Therapeutics stock
Once you have identified the best place to buy Neuphoria Therapeutics stock, it's crucial to research their stock before you buy, so you actually comprehend the risk and upside.
Neuphoria Therapeutics quick stats
NEUP Price
$5.20
1w %
0.64%
1y %
-54.86%
5y %
N/A
P/E
-2.03x
P/B
1.06x
P/S
19.62x
PEG
N/A
Revenue
$416.80k
Earnings
-$1.81M
Fore. Rev. Growth
127.33%
Fore. Earn. Growth
N/A
Market Cap
$9.14M
Next Earnings
N/A
Next Dividend
N/A
NEUP Overview
WallStreetZen was created to help everyday investors perform more accurate fundamental analysis.
Last year, NEUP revenue was $416.80k. Over the past two year, NEUP's revenue has gone up by 52.53% per year. This was faster than the Biotechnology industry average of 44.31%.
No, Neuphoria Therapeutics doesn't provide an income stream by paying out dividends.
Get opinions from other traders
One of the major reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to learn what other investors have to say.
Step 5: Execute your NEUP trade
There are two main order types:
Market order: A market order is an order to buy or sell a stock at the best available price. Market orders are usually the best for newer investors.
Limit order: A limit order is an order to buy or sell a security at a specific price (or better). If you want to be sure you're buying or selling at a particular dollar amount, place a limit order.
Press the Open button and your broker will execute your order.
If you want additional assistance investing in stocks on eToro, watch the helpful video below:
How much does it cost to buy one Neuphoria Therapeutics share?
As of Apr 21, 2025, it costs $5.20 to buy one share of Neuphoria Therapeutics stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $2, you can buy 0.385 shares of NEUP.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.